Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Asthma ; 47(3): 233-7, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20394508

ABSTRACT

BACKGROUND: Eotaxin, a CC chemokine, plays an important role in inflammation of airway allergic diseases. The authors investigated the activities of caffeic acid phenethyl ester (CAPE), the active component of propolis, in regulating eotaxin production in human lung fibroblast. MATERIAL AND METHODS: The authors used human lung fibroblasts, CCD-11Lu cells, stimulated with interleukin-13 (IL-13) and tumor necrosis factor-alpha (TNF-alpha), to induce eotaxin secretion. The cells were treated with CAPE of different concentrations and pretreatment duration to check its inhibition in eotaxin production. Enzyme-linked immunosorbent assay (ELISA) was used to measure eotaxin secretion; electrophoretic mobility shift assay (EMSA) to check nuclear factor kappa B (NF-kappaB)-promoter binding; and Western blot to quantitate the cyplasmic inhibitor of NF-kappaB (IkappaB) and nuclear NF-kappaB p65. RESULTS: CAPE inhibited the production of eotaxin in CCD-11Lu cells stimulated by IL-13 and TNF-alpha combination in a dose- and time-dependent manner. The authors also demonstrated CAPE to be able to inhibit NF-kappaB activation in CCD-11Lu cells. CONCLUSION: The authors suggest that CAPE is a promising agent in controlling eosinophils influx in human airway.


Subject(s)
Caffeic Acids/pharmacology , Chemokine CCL11/biosynthesis , Phenylethyl Alcohol/analogs & derivatives , Cells, Cultured , Dose-Response Relationship, Drug , Fibroblasts/metabolism , Humans , Interleukin-13/pharmacology , Lung/cytology , Lung/metabolism , NF-kappa B/metabolism , Phenylethyl Alcohol/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
2.
Ultrasound Med Biol ; 33(3): 379-88, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17207906

ABSTRACT

The lung cancer blood supply originates from the bronchial artery. If vessel signals within pulmonary lesions can be confirmed to be those of the pulmonary artery, color Doppler ultrasound (US) should be able to predict and differentiate benign lesions from lung cancers. Two hundred sixty-four patients with abutting thoracic lesions (including 125 lung cancers and 139 benign lesions) underwent color Doppler US examinations. A pulsatile flow, with the vessel signal length on sonographic appearance > or =1 cm demonstrated by color Doppler US, was arbitrarily defined as a pulmonary artery vessel signal. Of the 264 thoracic lesions, 73 (58%) lung cancers and 107 (77%) benign lesions had detectable color Doppler US pulsatile flow vessel signals. Analyzing the pulsatile flow vessel signals, the color Doppler US pulmonary artery vessel signal was present in 74 (53%) benign lesions, but was found in only two (2%) lung cancers of a specific alveolar cell carcinoma with lobar consolidation. Using the pulmonary artery vessel signal, color Doppler US can be valuable in predicting and differentiating benign lesions from lung cancers (p < 0.0001, sensitivity = 0.53, specificity = 0.98 and positive likelihood ratio 26.5). In conclusion, color Doppler US pulmonary artery vessel signal sign is useful in predicting and differentiating benign lesions from lung cancers.


Subject(s)
Lung Diseases/diagnostic imaging , Pulmonary Artery/diagnostic imaging , Ultrasonography, Doppler, Color/methods , Adolescent , Adult , Aged , Aged, 80 and over , Diagnosis, Differential , Female , Humans , Lung Diseases/physiopathology , Lung Neoplasms/blood supply , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/physiopathology , Male , Middle Aged , Pneumonia/diagnostic imaging , Pulmonary Artery/physiopathology , Pulsatile Flow/physiology
3.
J Gastroenterol ; 40(1): 11-5, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15692784

ABSTRACT

BACKGROUND: A high prevalence of gastroesophageal reflux disease (GERD) in asthmatic patients has been reported from North America and Europe. However, only a few data from Asia are available. This study evaluated the incidence of abnormal gastroesophageal reflux (GER) in asthmatic patients in Taiwan. METHODS: Fifty-six consecutive ambulatory patients with clinically stable asthma (41 men and 15 women; age, 57.7 +/- 12.4 years; range, 24 to 74 years) were evaluated prospectively. All patients underwent esophagogastroduodenoscopy, esophageal manometry, and 24-h esophageal pH monitoring. RESULTS: Twenty-nine patients (51.8%) had abnormal GER, as defined by 24-h esophageal pH monitoring. There were 42 patients without endoscopic evidence of esophagitis, 10 patients with Los Angeles (LA) grade A esophagitis, and 4 patients with LA grade B esophagitis. The esophageal motility function studies revealed 21 patients with normal esophageal motility, 23 patients with ineffective esophageal motility (IEM), and 12 patients with nonspecific esophageal motility disorders other than IEM. Although the lower esophageal sphincter (LES) basal pressure was higher in the patients without GER, the difference was not statistically significant. CONCLUSIONS: Abnormal GER seems to be a clinically significant problem in asthmatic patients in Taiwan. The most common esophageal motility dysfunction is IEM. However, the status of Helicobacter pylori infection plays no role in abnormal GER.


Subject(s)
Asthma/epidemiology , Asthma/physiopathology , Gastroesophageal Reflux/epidemiology , Gastroesophageal Reflux/physiopathology , Adult , Aged , Asthma/complications , Endoscopy, Gastrointestinal , Esophageal Sphincter, Lower/physiopathology , Esophagitis, Peptic/epidemiology , Esophagitis, Peptic/physiopathology , Female , Gastroesophageal Reflux/complications , Humans , Hydrogen-Ion Concentration , Male , Manometry , Middle Aged , Prevalence , Prospective Studies , Taiwan/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...